胃状细胞癌:新辅助化疗是否总是有效的? 一个案例报告报告
Eya Rahmouni1, Saida Sakhri1, Amira Allani1
1Department of Surgical Oncology, Salah Azaiez Institute, Tunis, Tunisia.
International journal of surgery case reports
|May 10, 2025
概括
胃状细胞癌 (GSCC) 是一种罕见的癌症. 这一案例突显了局部先进的GSCC中对新辅助化疗的分离治疗反应,强调了需要进一步研究的需要.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
背景情况:
- 胃状细胞癌 (GSCC) 是一种非常罕见的恶性瘤.
- 临床呈现的GSCC往往模仿更常见的胃瘤.
更多相关视频
06:21Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
03:32Single Incision Plus One Port Laparoscopic Proximal Gastrectomy with Double Channel Anastomosis for Gastric Cancer Treatment
Published on: December 27, 2024
相关概念视频
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
151
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
151
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
137
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
137